Medicines Patent Pool Has Another Big Pharma Deal
For the past two years, the Medicines Patent Pool has largely met with indifference from the pharmaceutical industry. Only one drugmaker, Gilead Sciences, agreed to license any of its medicines to the non-profit initiative, which was created by UNITAID to streamline licensing so that generic versions of patented HIV meds could be offered at lower prices in poor countries.
Now, though, after extensive lobbying and negotiations another drugmaker has signed on. ViiV Healthcare, which is a joint venture between GlaxoSmithKline (GSK) and Pfizer, has agreed to license abacavir, also known as Ziagen,for children. MPP and ViiV hav...
Source: Pharmalot - February 27, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Abacavir AIDS Dolutegravir Gilead Sciences GlaxoSmithKline HIV Pfizer Unitaid Viiv Healthcare Ziagen Source Type: blogs
